| Literature DB >> 33926992 |
Elisabeth Doran1,2, Enda Barron3, Laura Healy4, Lorraine O'Connor5, Cara Synnott6, Clíona Ní Cheallaigh7,8, Colin Doherty6,9.
Abstract
Homelessness is associated with significant psychosocial and health disparities. The rate of epilepsy among this cohort is eight times greater than that in the settled population, and the associated morbidity is higher due to lack of integrated care, difficulties with treatment adherence, substance abuse and poor social circumstances. There is a high rate of seizure-related death in homeless patients. Seizures are one of the most common neurological cause for emergency department presentation among this population. The aim of this quality improvement project was to use a multistakeholder co-production approach to design a new pathway of care for homeless patients with epilepsy to improve access to specialist epilepsy care and to strengthen the links between hospital and community teams who manage this population. After several years of observation, stakeholder engagement and numerous tests of change, we have created a new care pathway and developed bespoke tools for primary care providers and for physicians working in the emergency department to enable them to assess and manage patients as they present, as well as provide access to remote epilepsy specialist support. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: chronic disease management; healthcare quality improvement; patient-centred care; standards of care
Year: 2021 PMID: 33926992 PMCID: PMC8094364 DOI: 10.1136/bmjoq-2021-001367
Source DB: PubMed Journal: BMJ Open Qual ISSN: 2399-6641
Figure 1Timeline of processes and outcomes of our quality improvement project between 2016 to 2020. ICP, Integrated Care Pathway; PDSA, Plan–Do–Study–Act.
Figure 2Newly established Clinical Pathways for homeless patients who are referred to our service.
Characteristics, process measures and comparison of two cohorts before and after the development of new pathways
| Baseline | New | Total | P value | |
| (n=46) | (n=46) | (n=92) | ||
| Age | ||||
| Mean (SE mean) | 37 | 40 | 39 | 0.554 |
| Median (range) | (21–65) | (20–65) | (20–65) | |
| Gender, n (%) | ||||
| Male | 34 (74) | 36 (78) | 70 (76) | 0.807 |
| Female | 12 (26) | 10 (22) | 22 (24) | |
| Type of referral, n (%) | ||||
| Inpatient consult | 4 (9) | 17 (37) | 21 (23) | 0.000 |
| Primary care | 13 (28) | 24 (52) | 37 (37) | |
| ICP | 29 (63) | 5 (11) | 34 (40) | |
| Epilepsy diagnosis, n (%) | ||||
| New diagnosis | 1 (2) | 3 (7) | 4 (4) | 0.000 |
| Established diagnosis | 13 (28) | 26 (57) | 39 (42) | |
| No diagnosis | 0 | 4 (9) | 4 (4) | |
| Substance-related seizures | 3 (7) | 10 (22) | 13 (14) | |
| Unknown | 29 (63) | 3 (7) | 32 (35) | |
| Ability contact patient or communicate plan | 10 (22) | 46 (100) | 56 (61) | 0.000 |
| Ability to advise on management | 12 (26) | 46 (100) | 58 (63) | 0.000 |
| Change to management advised | 5 (11) | 27 (59) | 32 (35) | 0.000 |
ICP, Integrated Care Pathway.